Botanix (ASX:BOT) share price falls despite big tax refund

The Botanix Pharmaceuticals (ASX: BOT) share price is edging higher this morning. We look at the company's latest release.

| More on:
falling asx share price represented by business man giving thumbs down gesture

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Botanix Pharmaceuticals Ltd (ASX: BOT) shares are edging lower today despite the company reporting it has received a research and development (R&D) tax refund. At the time of writing, the Botanix share price has fallen 3.45% lower to 14 cents.

What did Botanix Pharmaceuticals report?

In this morning's ASX release, Botanix reported it has received an R&D Tax Incentive refund of $6.87 million. The company had $19.2 million in cash as at 31 December.

Botanix stated that the tax refund alongside positive data from its BTX 1801 antimicrobial Phase 2a study places it in a strong position for clinical programs and corporate development in the 2021 calendar year.

The federal government provides the R&D Tax Incentive to support companies in their research and development programs. Companies can receive refunds of up to 43.5% of eligible R&D expenditure.

Commenting on the tax refund, Vince Ippolito, president and executive chair, said:

The receipt of the R&D refund provides the company with a strong financial position and funding flexibility across our product development pipeline. Following the announcement of our successful BTX 1801 study data last week, Botanix is well positioned to execute on our dermatology and antimicrobial programs and extend our leading position in synthetic cannabinoid research and development.

Botanix Pharmaceuticals share price and company snapshot

Botanix Pharmaceuticals is a clinical-stage cannabinoid therapeutics company. It focuses on developing safe and effective topical treatments for serious skin conditions. The company has an exclusive license to use a proprietary drug delivery system, Permetrex, for direct skin delivery of active pharmaceuticals in all skin diseases.

Botanix shares listed on the ASX in January 1985. The company has a current market capitalisation of $141 million.

Year to date, the Botanix share price is up 7.7% and has surged around 600% from its 30 March lows.

Over the past 12 months, Botanix shares have gained 55%. By comparison, the All Ordinaries Index (ASX: XAO) is down 1% over the past calendar year.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Market News

Here are the top 10 ASX 200 shares today

The ASX was back to fine form this Thursday...

Read more »

A young boy wearing a hat, sunnies and striped singlet looks fierce and flexes his arm in victory.
Energy Shares

Top broker says Boss Energy shares have 29% upside

Nuclear energy continues to be an emerging theme for investors.

Read more »

A man looks down with fright as he falls towards the ground.
Share Fallers

Why 29Metals, Guzman Y Gomez, Mesoblast, and Pilbara Minerals shares are falling today

These shares are having a tough time on Thursday. What's going on?

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Bravura, HMC, Magellan, and Perseus shares are pushing higher today

These shares are having a good session on Thursday. But why?

Read more »

Three young people lie in the surf on a beach wearing santa hats.
Share Market News

Will ASX 200 investors be gifted with a 'Santa rally'?

After a strong run in 2024, can the Santa rally send the ASX 200 to new records?

Read more »

A businessman stacks building blocks.
Technology Shares

Why has this ASX 200 tech stock rocketed 38% in a month?

The stars aligned for this stock over the past month.

Read more »

Three rockets heading to space
Share Gainers

3 ASX biotech shares rocketing 10% to 26% on BIG news!

Investors are sending these three ASX biotech stocks flying higher on Thursday.

Read more »

Broker looking at the share price.
Broker Notes

Here's the latest broker upgrades on ASX All Ords shares

Let's dive in.

Read more »